- Apr 2, 2009
- 5,171
- 13,288
- 67
CTFK/ACS/AHA/ALA go nuts over approval of Rehberg Amendment by US House Appropriations Committee to require FDA to base product (including tobacco) regulations that "restrict the use of a substance or a compound" upon sound science (i.e. the weight of toxicological evidence, epidemiological evidence, and risk assessments) instead of upon "cost or consumer behavior"; measure could benefit tobacco harm reduction, consumer and public health.
House Appropriations Amendment Would Weaken FDA's Authority over Tobacco, Unleash Big Tobacco on... -- WASHINGTON, June 1, 2011 /PRNewswire-USNewswire/ --
House GOP pushes back against health measures affecting school lunches, tobacco - The Washington Post
The full text of the Rehberg Amendment is:
"None of the funds made available by this Act may be used by the Food and Drug Administration to write, prepare, develop or publish a proposed, interim, or final rule, regulation or guidance that is intended to restrict the use of a substance or a compound unless the Secretary bases such rule, regulation or guidance on hard science (and not on such factors as cost and consumer behavior), and determines that the weight of toxicological evidence, epidemiological evidence, and risk assessments clearly justifies such action, including a demonstration that a product containing such substance or compound is more harmful to users than a product that does not contain such substance or compound, or in the case of pharmaceuticals, has been demonstrated by scientific study to have none of the purported benefits."
House Appropriations Amendment Would Weaken FDA's Authority over Tobacco, Unleash Big Tobacco on... -- WASHINGTON, June 1, 2011 /PRNewswire-USNewswire/ --
House GOP pushes back against health measures affecting school lunches, tobacco - The Washington Post
The full text of the Rehberg Amendment is:
"None of the funds made available by this Act may be used by the Food and Drug Administration to write, prepare, develop or publish a proposed, interim, or final rule, regulation or guidance that is intended to restrict the use of a substance or a compound unless the Secretary bases such rule, regulation or guidance on hard science (and not on such factors as cost and consumer behavior), and determines that the weight of toxicological evidence, epidemiological evidence, and risk assessments clearly justifies such action, including a demonstration that a product containing such substance or compound is more harmful to users than a product that does not contain such substance or compound, or in the case of pharmaceuticals, has been demonstrated by scientific study to have none of the purported benefits."